Neuroprotective glycosphingolipid

Class

Neuroprotective glycosphingolipid (GM1 ganglioside / monosialotetrahexosylganglioside) encapsulated in a proprietary liposomal formulation for intravenous administration

Pathway

GM1 ganglioside neuroprotective/neurotrophic signaling; liposomal encapsulation is designed to cross the blood-brain barrier more efficiently than free GM1, increasing brain delivery

Notes

original target text: Neuroprotective glycosphingolipid (GM1 ganglioside / monosialotetrahexosylganglioside) encapsulated in a proprietary liposomal formulation for intravenous administration

GM1 ganglioside is a glycosphingolipid, a lipid bearing a complex sugar chain, that is highly enriched in neuronal cell membranes, particularly within specialized membrane microdomains. It participates in maintaining membrane stability, calcium regulation, and modulates neurotrophic signaling pathways that support neuron survival, neurite growth, and repair after injury. Because of these properties, GM1 has been studied as a potential neuroprotective and neuroregenerative agent in conditions involving neuronal injury or degeneration, such as ischemic stroke, spinal cord injury, and Parkinson's disease, where preserving or restoring neuronal signaling capacity could limit functional loss. A key pharmacological challenge is that GM1, administered as a free molecule, penetrates the blood-brain barrier poorly, limiting how much reaches the central nervous system after systemic dosing. Encapsulating GM1 within a liposome, a synthetic lipid vesicle, is intended to improve its transport across the blood-brain barrier and protect it from premature breakdown in circulation, increasing the fraction that reaches brain tissue after intravenous administration. This delivery strategy reflects a broader principle in neuropharmacology: pairing a biologically active but poorly bioavailable molecule with a carrier system designed to overcome anatomical barriers rather than modifying the molecule itself.